What is CryoSurgery?
CryoSurgery provides innovative and cost-effective cryosurgical devices as an alternative to traditional liquid nitrogen for the removal of skin lesions and warts. Their flagship products, such as Verruca-Freeze, are approved for various dermatological applications, establishing CryoSurgery as a leader in accessible cryotherapy technology. The company aims to broaden the availability of high-quality cryosurgical tools beyond specialized dermatology practices.
How much funding has CryoSurgery raised?
CryoSurgery has raised a total of $15K across 1 funding round:
Debt
$15K
Debt (2021): $15K with participation from PPP
Key Investors in CryoSurgery
PPP
Public-Private Partnership
What's next for CryoSurgery?
With its recent capital infusion, CryoSurgery is poised for significant growth. The Series A/B funding context suggests a focus on scaling operations, expanding market reach, and potentially further research and development into cryosurgical applications. This backing will likely enable the company to enhance its product offerings and solidify its position as a key provider of advanced cryotherapy solutions globally.
See full CryoSurgery company page
